| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| J Spillane, G Christofi, K C Sidle, D M Kullmann, R S Howar. Myasthenia gravis and neuromyelitis opica: A causal link. Multiple sclerosis and related disorders. vol 2. issue 3. 2015-04-17. PMID:25877729. |
neuromyelitis optica (nmo) and myasthenia gravis (mg) are rare antibody mediated disorders of the central nervous system (cns) and neuromuscular junction (nmj) respectively. |
2015-04-17 |
2023-08-13 |
Not clear |
| Metha Apiwattanakul, Chayut Kasemsu. NMO spectrum disorders comprise the major portion of CNS inflammatory diseases in Thai patients: A cross sectional study. Multiple sclerosis and related disorders. vol 3. issue 1. 2015-04-17. PMID:25877974. |
neuromyelitis optica (nmo) is more prevalent than multiple sclerosis (ms) in the asian population. |
2015-04-17 |
2023-08-13 |
Not clear |
| Vincent Hanoux, Laurent Coulbault, Nathalie Derache, Philippe Cabre, Jérôme De Seze, Romain Marignier, Gabrielle Rudolf, Audrey Emmanuelle Dugué, Stéphane Allouche, Gilles Defe. No evidence for genetic association between glutamate transporter EAAT2 and Devic's neuromyelitis optica in caucasians and afro-caribbeans. Multiple sclerosis and related disorders. vol 3. issue 1. 2015-04-17. PMID:25877978. |
devic's neuromyelitis optica (nmo) is a severe inflammatory and autoimmune disease producing demyelinating lesions. |
2015-04-17 |
2023-08-13 |
human |
| Jennifer Graves, Uma Vinayagasundaram, Ellen M Mowry, Ian R Matthews, Julia A Marino, Jing Cheng, Emmanuelle Wauban. Effects of rituximab on lymphocytes in multiple sclerosis and neuromyelitis optica. Multiple sclerosis and related disorders. vol 3. issue 2. 2015-04-17. PMID:25878012. |
to investigate the effect of rituximab, a b-cell targeted therapy that is used in the treatment of multiple sclerosis (ms) and neuromyelitis optica (nmo), on other immune cells such as cd4+ and cd8+ t-cells in patients with ms and nmo. |
2015-04-17 |
2023-08-13 |
Not clear |
| Annika Plate, Joachim Havla, Tania Kümpfe. Late-onset neutropenia during long-term rituximab therapy in neuromyelitis optica. Multiple sclerosis and related disorders. vol 3. issue 2. 2015-04-17. PMID:25878016. |
late-onset neutropenia (lon) has been described as a side effect of rituximab (rx) therapy in patients with rheumatological and/or haematooncological diseases but not neuromyelitis optica (nmo). |
2015-04-17 |
2023-08-13 |
Not clear |
| Philippe Rizek, David Nicolle, Keng Yeow Tay, Marcelo Kremenchutzk. Bilateral trochlear nerve palsy in a patient with neuromyelitis optica. Multiple sclerosis and related disorders. vol 3. issue 2. 2015-04-17. PMID:25878017. |
we present a unique case of isolated bilateral simultaneous cranial nerve (cn) iv palsy in a patient with neuromyelitis optica (nmo). |
2015-04-17 |
2023-08-13 |
Not clear |
| Naoko Saito, Masato Inoue, Kanehiro Hasuo, Takashi Kanbayashi, Shigeo Murayama, Sosuke Takeuch. [A 39 years old woman responding to modafinil with bilateral hypothalamic lesion associated with hyperthermia and hypersomnia: a case report]. Rinsho shinkeigaku = Clinical neurology. vol 54. issue 7. 2015-04-13. PMID:25087555. |
there is a number of reports about neuromyelitis optica (nmo) with hypothalamic lesions. |
2015-04-13 |
2023-08-13 |
Not clear |
| I-Jun Chou, William P Whitehouse, Huei-Shyong Wang, Radu Tanasescu, Cris S Constantinesc. Diagnostic modalities in multiple sclerosis: perspectives in children. Biomedical journal. vol 37. issue 2. 2015-04-10. PMID:24732659. |
however, it is difficult to differentiate ms from acute disseminated encephalomyelitis (adem) and neuromyelitis optica (nmo) in pediatric patients, even considering the clinical, magnetic resonance imaging (mri), and paraclinical findings, because the first presentation of inflammatory demyelination in children is often atypical. |
2015-04-10 |
2023-08-13 |
Not clear |
| Juan F Cardona, Lucila Kargieman, Vladimiro Sinay, Oscar Gershanik, Carlos Gelormini, Lucia Amoruso, María Roca, David Pineda, Natalia Trujillo, Maëva Michon, Adolfo M García, Daniela Szenkman, Tristán Bekinschtein, Facundo Manes, Agustín Ibáñe. How embodied is action language? Neurological evidence from motor diseases. Cognition. vol 131. issue 2. 2015-04-09. PMID:24594627. |
aces were measured in three patient groups - early parkinson's disease (epd), neuromyelitis optica (nmo), and acute transverse myelitis (atm) patients - as well as their respective healthy controls. |
2015-04-09 |
2023-08-12 |
human |
| Hongyang Li, Zihao Liu, Yan Gong, Zhaocai Jiang, Yixin Zhang, Yanli Dai, Yan Zhang, Shihui We. Application of immunosuppressant facilitates the therapy of optic neuritis combined with Sjögren's syndrome. Chinese medical journal. vol 127. issue 17. 2015-04-09. PMID:25189952. |
optic neuritis (on) is often the first symptom of multiple sclerosis (ms) and neuromyelitis optica (nmo) while there has been very little research reported on on combined with sjögren's syndrome (ss). |
2015-04-09 |
2023-08-13 |
Not clear |
| Chen Tingjun, Li Zhaohui, Jiang Zhaocai, Liu Zihao, Xu Quangang, Huang Dehui, Lin Qing, Wei Shihu. Changes of CXCL12, CXCL14 and PDGF levels in the brain of patients with idiopathic demyelinating optic neuritis and neuromyelitis optica. Journal of neuroimmunology. vol 279. 2015-04-07. PMID:25669992. |
the present study compared the difference in the brain levels of these chemokines between patients with idiopathic demyelinating optic neuritis (idon) and neuromyelitis optica (nmo) by measuring their concentrations in the cerebrospinal fluid using an enzyme linked immunosorbent assay. |
2015-04-07 |
2023-08-13 |
Not clear |
| Jing-Cong Zhuang, Zhu-Yi Huang, Gui-Xian Zhao, Hai Yu, Zhen-Xin Li, Zhi-Ying W. Variants of CYP27B1 are associated with both multiple sclerosis and neuromyelitis optica patients in Han Chinese population. Gene. vol 557. issue 2. 2015-04-06. PMID:25542806. |
multiple sclerosis (ms) and neuromyelitis optica (nmo) are chronic demyelinating diseases of the central nervous system (cns). |
2015-04-06 |
2023-08-13 |
Not clear |
| Maja Kitic, Sonja Hochmeister, Isabella Wimmer, Jan Bauer, Tatsuro Misu, Simone Mader, Markus Reindl, Kazuo Fujihara, Hans Lassmann, Monika Brad. Intrastriatal injection of interleukin-1 beta triggers the formation of neuromyelitis optica-like lesions in NMO-IgG seropositive rats. Acta neuropathologica communications. vol 1. 2015-03-31. PMID:24252536. |
neuromyelitis optica (nmo) is a severe, disabling disease of the central nervous system (cns) characterized by the formation of astrocyte-destructive, neutrophil-dominated inflammatory lesions in the spinal cord and optic nerves. |
2015-03-31 |
2023-08-12 |
rat |
| Maria Pohl, Naoto Kawakami, Maja Kitic, Jan Bauer, Rui Martins, Marie-Therese Fischer, Joana Machado-Santos, Simone Mader, Joachim W Ellwart, Tatsuro Misu, Kazuo Fujihara, Hartmut Wekerle, Markus Reindl, Hans Lassmann, Monika Brad. T cell-activation in neuromyelitis optica lesions plays a role in their formation. Acta neuropathologica communications. vol 1. 2015-03-31. PMID:24367907. |
neuromyelitis optica (nmo) is an inflammatory demyelinating disease of the central nervous system (cns), which is characterized by the presence of pathogenic serum autoantibodies against aquaporin 4 (aqp4) in the vast majority of patients. |
2015-03-31 |
2023-08-12 |
human |
| So-Young Huh, Ju-Hong Min, Woojun Kim, Su-Hyun Kim, Ho Jin Kim, Byung-Jo Kim, Byoung Joon Kim, Kwang Ho Le. The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders. Multiple sclerosis (Houndmills, Basingstoke, England). vol 20. issue 6. 2015-03-30. PMID:24072726. |
although neuromyelitis optica (nmo) is a central nervous system (cns) autoimmune disease distinct from multiple sclerosis (ms). |
2015-03-30 |
2023-08-12 |
Not clear |
| S Namgoong, J S Bae, H S Cheong, J-H Kim, J Y Kim, L H Kim, H J Kim, H D Shi. No association between CCL2 gene polymorphisms and risk of inflammatory demyelinating diseases in a Korean population. Tissue antigens. vol 84. issue 2. 2015-03-30. PMID:24786287. |
inflammatory demyelinating disease (idd), which includes multiple sclerosis (ms) and neuromyelitis optica (nmo), affects the central nervous system. |
2015-03-30 |
2023-08-13 |
Not clear |
| Sven Jarius, Friedemann Paul, Kai Fechner, Klemens Ruprecht, Ingo Kleiter, Diego Franciotta, Marius Ringelstein, Florence Pache, Orhan Aktas, Brigitte Wildeman. Aquaporin-4 antibody testing: direct comparison of M1-AQP4-DNA-transfected cells with leaky scanning versus M23-AQP4-DNA-transfected cells as antigenic substrate. Journal of neuroinflammation. vol 11. 2015-03-30. PMID:25074611. |
neuromyelitis optica (nmo, devic syndrome) is associated with antibodies to aquaporin-4 (nmo-igg/aqp4-ab) in the majority of cases. |
2015-03-30 |
2023-08-13 |
Not clear |
| Jing Wang, Xin Li, Da-Qi Zhang, Chun-Sheng Yang, Yuan Qi, Min-Shu Li, Fu-Dong Shi, Li Yan. Quantitative analysis of aquaporin-4 antibody in longitudinally extensive transverse myelitis. Journal of neuroimmunology. vol 278. 2015-03-23. PMID:25595249. |
aquaporin-4 (aqp-4) antibody-positive longitudinally extensive transverse myelitis (letm) is referred to as a neuromyelitis optica (nmo) spectrum disorder. |
2015-03-23 |
2023-08-13 |
Not clear |
| Eoin P Flanagan, Brian G Weinshenker, Karl N Krecke, Vanda A Lennon, Claudia F Lucchinetti, Andrew McKeon, Dean M Wingerchuk, Elizabeth A Shuster, Yujuan Jiao, Erika S Horta, Sean J Pittoc. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders. JAMA neurology. vol 72. issue 1. 2015-03-18. PMID:25384099. |
short transverse myelitis (stm; <3 vertebral segments) is considered noncharacteristic of neuromyelitis optica (nmo) spectrum disorders (nmosds). |
2015-03-18 |
2023-08-13 |
Not clear |
| M C Dalakas, W N Lösche. 7th International Immunoglobulin Conference: Interlaken Leadership Awards. Clinical and experimental immunology. vol 178 Suppl 1. 2015-03-17. PMID:25546789. |
dr geis shows improved disease scores after ivig treatment in a mouse model of neuromyelitis optica (nmo). |
2015-03-17 |
2023-08-13 |
mouse |